SPARC and metabolic dysfunction-associated steatohepatitis: To identify other candidate genes which positively correlated with SPARC in NASH patients and whose expression could be different between patients with fatty liver and NASH, we studied the 2758 genes that present a strong correlation with SPARC (Figure 3B) and explored which ones were differentially expressed in NASH and NAFL stages.